Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Fu Lee

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Contemporary Clinical Trials|March 29, 2026
Internal pilot sample size re-estimation for the B-free trial: A case study of a cluster randomized crossover trialShun-Fu Lee, Keyun Zhou, Jessica Spence
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 21, 2018
When and how should we cluster and cross over: methodological and ethical issues (letter 2)Shun Fu Lee, Shrikant I Bangdiwala, Jessica Spence, et al.
Diabetes Research and Clinical Practice|November 13, 2023
Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trialAnne Wang, Sibylle Hess, Shun Fu Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2026
An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical TrialsJiajun Yan, Brittany Humphries, Menglu Che, et al.
American Heart Journal|September 7, 2016
Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failurePayam Yazdan-Ashoori, Shun Fu Lee, Quazi Ibrahim, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic PeopleHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.
American Heart Journal|December 6, 2019
Variations in stepped-wedge cluster randomized trial design: Insights from the Patient-Centered Care Transitions in Heart Failure trialRudy R Unni, Shun Fu Lee, Lehana Thabane, et al.
Diabetes, Obesity & Metabolism|July 3, 2026
A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at BaselineHertzel C Gerstein, Zayeeda Labiba, Sibylle Hess, et al.
Journal of the American College of Surgeons|May 29, 2020
Selecting the Optimal Level of Clustering: An Approach to Trial Design Decision MakingGraham R McClure, Emilie P Belley-Cote, Jessica Spence, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2022
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN TrialTali Cukierman-Yaffe, Shun-Fu Lee, Guillaume Pare, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Contemporary Clinical Trials|March 29, 2026
Internal pilot sample size re-estimation for the B-free trial: A case study of a cluster randomized crossover trialShun-Fu Lee, Keyun Zhou, Jessica Spence
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 21, 2018
When and how should we cluster and cross over: methodological and ethical issues (letter 2)Shun Fu Lee, Shrikant I Bangdiwala, Jessica Spence, et al.
Diabetes Research and Clinical Practice|November 13, 2023
Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trialAnne Wang, Sibylle Hess, Shun Fu Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2026
An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical TrialsJiajun Yan, Brittany Humphries, Menglu Che, et al.
American Heart Journal|September 7, 2016
Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failurePayam Yazdan-Ashoori, Shun Fu Lee, Quazi Ibrahim, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic PeopleHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.
American Heart Journal|December 6, 2019
Variations in stepped-wedge cluster randomized trial design: Insights from the Patient-Centered Care Transitions in Heart Failure trialRudy R Unni, Shun Fu Lee, Lehana Thabane, et al.
Diabetes, Obesity & Metabolism|July 3, 2026
A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at BaselineHertzel C Gerstein, Zayeeda Labiba, Sibylle Hess, et al.
Journal of the American College of Surgeons|May 29, 2020
Selecting the Optimal Level of Clustering: An Approach to Trial Design Decision MakingGraham R McClure, Emilie P Belley-Cote, Jessica Spence, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2022
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN TrialTali Cukierman-Yaffe, Shun-Fu Lee, Guillaume Pare, et al.
Pageof 8